Claudia Patricia Valencia Molina

Claudia Patricia Valencia Molina

Auto-generated profile, based on publicly available information

Claudia Patricia Valencia Molina

School of Nursing, PROMESA Research Group, Universidad del Valle, Cali, Colombia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2000 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
SHS. David Hudnall
S. David Hudnall
CMClaudia P. Molina
Claudia P. Molina
The detailed immunophenotype of peripheral blood lymphocytes from a neonate with pertussis was determined by flow cytometry and compared with results

4 August 2008 in Applied Nursing Research
Verified
Journal Article
Closed access
ICI.B. Corless
I.B. Corless
JVJoachim G Voss
Joachim G Voss
PNP.K. Nicholas
P.K. Nicholas
EBE.H. Bunch
E.H. Bunch
CBC.A. Bain
C.A. Bain
CVC.P. Valencia
C.P. Valencia

8 October 2010 in Colombia Medica
Verified
Journal Article
Open access
PDF file
CVClaudia Patricia Valencia
Claudia Patricia Valencia
GCGladys Eugenia Canaval
Gladys Eugenia Canaval
DMDiana Marín
Diana Marín
CPCarmen J. Portillo
Carmen J. Portillo
Antecedents: The Human Immunodeficiency Virus is currently considered a chronic disease; hence, quality of life is an important goal for those suffering the disease or living with someone afflicted by the virus.Objectives: We sought to measure the quality of life in individuals living with acquired immunodeficiency syndrome virus and establish its relationship with socio-demographic and clinical variables. Methods: This is a cross-sectional, descriptive study with a sample of 137 HIV-infected individuals attending three healthcare institutions in the city of Cali, Colombia. Quality of life was measured via the HIV/AIDS-Targeted Quality of Life (HAT-QoL) instrument. The descriptive analyses included mean and standard deviation calculations. To determine the candidate variables, we used the student t test and the Pearson correlation. The response variable in the multiple linear regression was the score for quality of life.Results: Some 27% of the sample were women and 3% were transgender; the mean age of the sample was 35 + 10.2 years; 88% had some type of health insurance; 27% had been diagnosed with AIDS, and 64% were taking antiretroviral medications at the time of the study. Quality of life was measured through a standard scale with scores from 0 to 100. Participants’ global quality of life mean was 59 + 17.8. The quality-of-life dimensions with the highest scores were sexual function, satisfaction with the healthcare provider, and satisfaction with life. The highest quality-of-life scores were obtained by participants who received antiretroviral therapy, had health insurance, lower symptoms of depression, low frequency and intensity of symptoms, and no prior reports of sexual abuse. Eight variables explained 53% of the variability of the global quality of life. Conclusions: Those receiving antiretroviral therapy and who report fewer symptoms best perceived their quality of life. Implications for practice: Healthcare providers, especially nursing professional face a challenge in caring to alleviate symptoms and contribute to improving the quality of life of their patients.

8 December 2025 in Journal of Urban Health
Verified
Journal Article
Open access
PDF file
FSFabiana Cristina Dos Santos
Fabiana Cristina Dos Santos
PAPanta Apiruknapanond
Panta Apiruknapanond
TWTongyao Wang
Tongyao Wang
CDCarol Dawson-Rose
Carol Dawson-Rose
CVClaudia P Valencia-Molina
Claudia P Valencia-Molina
RSRebecca Schnall
Rebecca Schnall
Despite advances in HIV treatment, disparities in healthcare access remain across low-income (LIC), middle-income (MIC), and high-income (HIC) countries, limiting access to clinical care, antiretroviral therapy, and viral load testing. This study developed the HIV Care Access Index (HIV-CAI) to measure and compare HIV care service access across countries and within geographic regions and examined associations with economic and health indicators. A cross-sectional survey was conducted between August 2021 and June 2023 across nine countries: Botswana, China, Colombia, Kenya, Nigeria, Puerto Rico, South Africa, Thailand, and the United States. Participants were adults living with HIV recruited from urban, suburban, and rural settings through HIV service organizations, sexual and gender minority centers, and resource-limited communities. The HIV-CAI was scored from 0 to 1 (worst to best access) across three domains: Access to HIV Clinical Care and Providers, Access to HIV Medication, and Access to Viral Load Testing. Among 1,598 participants, Botswana demonstrated the highest HIV care access (0.93), followed by Thailand (0.91) and Kenya (0.90), while Nigeria showed the lowest access (0.64). Access to HIV medication was relatively consistent across regions, whereas access to clinical care and providers was limited, particularly in rural areas. Countries with higher HIV burden, incidence, and prevalence were associated with better care access. The HIV-CAI reveals disparities in HIV care access across geographic areas. Future interventions should prioritize improving equitable access, particularly in rural areas and countries with lower overall access scores.

30 April 2021 in Universidad y Salud
Verified
Journal Article
Open access
PDF file
CVClaudia Patricia Valencia-Molina
Claudia Patricia Valencia-Molina
DBDelia Concepción Burgos-Davila
Delia Concepción Burgos-Davila
MSMartha Cecilia Sabala-Moreno
Martha Cecilia Sabala-Moreno
ÁSÁlvaro José Sierra-Perez
Álvaro José Sierra-Perez
Introducción: El condón es un método de prevención de las Infecciones de Transmisión Sexual (ITS) y del embarazo, sin embargo, su uso en jóvenes colombianos es bajo. Objetivo: Identificar las barreras y limitaciones individuales, culturales e institucionales, en el uso del condón en jóvenes universitarios. Materiales y métodos: Investigación cualitativa, con 4 grupos focales mixtos con jóvenes de 17 a 24 años. Se realizó codificación con el software ATLAS.TI y un análisis temático. Resultados: A nivel individual se evidencia baja intención de uso, la confianza en la pareja aleja el temor de una ITS y el embarazo es la principal preocupación que desplaza su uso por otro método anticonceptivo. A nivel cultural las relaciones de género refuerzan que la mujer es responsable de los anticonceptivos y el hombre del condón. A nivel institucional, las políticas y los servicios de salud limitan su acceso. La lógica mercantilista y el enfoque de riesgo limitan la distribución gratuita y masiva. Conclusiones: El reconocimiento de factores individuales y sociales que limitan el uso del condón, permite la promoción del cuidado de sí y del otro; además la orientación de estrategias para promover una adecuada atención en los servicios de Salud Sexual y Reproductiva.

1 July 2020 in Revista de Salud Pública
Verified
Journal Article
Open access
PDF file
CMCarlos Andres Quiroz Mora
Carlos Andres Quiroz Mora
CMClaudia Patricia Valencia Molina
Claudia Patricia Valencia Molina
Objetivo Evaluar la efectividad de las intervenciones de tipo estructural o multicomponente dirigidas al incremento del uso del preservativo en adolescentes y jóvenes, identificar las estrategias que conforman las intervenciones evaluadas y reconocer los modelos teóricos que sustentan dichas intervenciones.Metodología Diseño: revisión sistemática de la literatura. Fuente de datos: se consultaron las bases de datos MEDLINE vía OVID, Embase y CENTRAL para buscar estudios sobre intervenciones dirigidas al incremento del uso del preservativo en adolescentes y jóvenes. Selección de estudios: se seleccionaron un total de 7 investigaciones primarias donde se evaluaba el efecto de una intervención estructural o multicomponente para incrementar el uso del preservativo en adolescentes y jóvenes. La calidad de los estudios fue evaluada usando la herramienta para valoración de riesgo de sesgos de Cochrane.Resultados Cinco investigaciones mostraron cambios en los porcentajes del uso del preservativo con valores entre 53 % y el 68 %. Las intervenciones planteadas orientaban sus acciones más a nivel individual con estrategias como: educación sobre salud sexual, consejería en salud reproductiva, conocimientos acerca del preservativo, conocimientos acerca de las ITS/VIH. A nivel organizacional y del entorno iban dirigidas a la provisión de preservativos. Los modelos teóricos planteados en los estudios están centrados en la conducta humana, comportamiento del individuo y el aprendizaje social.Discusión Las intervenciones de tipo estructural que tienen como fin el incremento del uso del preservativo en adolescentes y jóvenes parecen mostrar cambios significativos a nivel individual, pero se desconocen los posibles cambios generados a nivel de la organización y del entorno.